Jim Cramer on Eli Lilly Stock “Needs Some Kind of Catalyst to Get Things Going”

Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer recently provided insights on. Cramer highlighted it as the most valuable health care company and commented:

“Now, let’s talk about the real contenders, okay. Let’s start with Eli Lilly, one I always said was going to get to trillion dollars, but it’s really stumbled here. It’s in fourth. I’m going to give it 15:1 odds now. Market cap of $780 billion for the most valuable healthcare company in the world. Lilly’s grown by leaps and bounds over the past few years, thanks to its revolutionary GLP-1 drug… It even got pretty darn close to trillionaire status last year with its market cap peaking at $912 billion in the summer of 2024, where I thought it was going to go over.

I was wrong. But the stock’s been choppy since then. We own it for the trust. Some of that’s because Lilly’s had to digest its gain. Some of it’s from worries about competition, both from Novo Nordisk that’s the maker of Ozempic, slashing prices, and from other drug companies who are working on similar products. Every time the news comes out, the stock gets hit so much due to potential regulatory headwinds, too. President Trump likes to talk about cracking down on high drug prices, although how far he’ll actually go, anybody’s guess.

As I mentioned, we own Lilly for the Charitable Trust, and I’ve been saying the stock needs some kind of catalyst to get things going. You know what, maybe the FDA has to approve GLP drug for a new indication, right? Maybe some progress on a pill form because people don’t like to take the shot. Until that happens, I’m putting Lilly’s odds of winning… the race of the trillion at 15 to one. Let’s see if they come up and surprise us with something on Thursday morning.”

Eli Lilly and Company (NYSE:LLY) develops pharmaceuticals for diabetes, obesity, oncology, immunology, neuroscience, and other therapeutic areas.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.